Biology and Health Sciences Department, Hendrix College, Conway, Arkansas, USA.
Epigenetics. 2022 Dec;17(13):2347-2355. doi: 10.1080/15592294.2022.2121073. Epub 2022 Sep 8.
Recent studies have unveiled an association between an L61R substitution within the human histone H3.3 protein and the presentation of neurodevelopmental disorders in two patients. In both cases, the mutation responsible for this substitution is encoded by one allele of the gene and, if this mutation is indeed responsible for the disease phenotypes, it must act in a dominant fashion since the genomes of these patients also harbour three other alleles encoding wild-type histone H3.3. In our previous work in yeast, we have shown that most amino acid substitutions at H3-L61 cause an accumulation of the Spt16 component of the yFACT histone chaperone complex at the 3' end of transcribed genes, a defect we have attributed to impaired yFACT dissociation from chromatin following transcription. In those studies, however, the H3-L61R mutant had not been tested since it does not sustain viability when expressed as the sole source of histone H3 in cells. In the present work, we show that H3-L61R impairs proper Spt16 dissociation from genes when co-expressed with wild-type histone H3 in haploid cells as well as in diploid cells that express the mutant protein from one of four histone H3-encoding alleles. These results, combined with other studies linking loss of function mutations in human Spt16 and neurodevelopmental disorders, provide a possible molecular mechanism underlying the neurodevelopmental disorders seen in patients expressing the histone H3.3 L61R mutant.
最近的研究揭示了人类组蛋白 H3.3 蛋白内 L61R 取代与两名患者神经发育障碍的表现之间存在关联。在这两种情况下,导致这种取代的突变是由基因的一个等位基因编码的,如果这种突变确实是疾病表型的原因,那么它必须以显性方式发挥作用,因为这些患者的基因组还含有另外三个编码野生型组蛋白 H3.3 的等位基因。在我们之前在酵母中的工作中,我们已经表明,H3-L61 处的大多数氨基酸取代会导致 yFACT 组蛋白伴侣复合物的 Spt16 成分在转录基因的 3'端积累,我们将这种缺陷归因于转录后 yFACT 与染色质的解离受损。然而,在这些研究中,尚未测试 H3-L61R 突变体,因为当它作为细胞中组蛋白 H3 的唯一来源表达时,它不能维持生存能力。在本工作中,我们表明 H3-L61R 会在单倍体细胞中与野生型组蛋白 H3 共同表达时以及在从四个组蛋白 H3 编码等位基因之一表达突变蛋白的二倍体细胞中,干扰 Spt16 从基因上的正确解离。这些结果与其他将人类 Spt16 功能丧失突变与神经发育障碍联系起来的研究相结合,为表达组蛋白 H3.3 L61R 突变体的患者中观察到的神经发育障碍提供了一个可能的分子机制。